GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Chemotherapy-Related Cognitive Impairment|Breast Cancer
Interventions: DRUG: Ganglioside-Monosialic Acid|DRUG: 250ml normal saline (NS)
Sponsor: Sun Yat-sen University